South Africa Approves New Immunotherapy for Rare Cancer

A groundbreaking immunotherapy has been registered in South Africa to treat a rare and aggressive head and neck cancer that often goes undiagnosed until advanced stages.

The treatment harnesses the body's own immune system to fight cancer, offering new hope for patients with nasopharyngeal carcinoma.